Best TWAS P=3.18e-22 · Best GWAS P=9.98e-22 conditioned to 5.63e-10
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | SSBP4 | 0.09 | 0.04 | lasso | 5 | 0.00 | 3.0e-01 | 7.3 | -7.3 | 4.0e-13 | -0.09 | 0.48 | 0.18 | FALSE |
2 | GTEx | Brain Hippocampus | DDX49 | 0.23 | -0.01 | lasso | 4 | -0.01 | 6.6e-01 | 5.6 | -6.2 | 6.3e-10 | -0.01 | 0.05 | 0.07 | TRUE |
3 | GTEx | Brain Nucleus accumbens basal ganglia | ELL | 0.17 | 0.00 | lasso | 5 | 0.01 | 2.1e-01 | 7.4 | -7.0 | 3.4e-12 | -0.07 | 0.13 | 0.06 | FALSE |
4 | GTEx | Cells Transformed fibroblasts | SSBP4 | 0.09 | 0.07 | lasso | 2 | 0.06 | 5.5e-05 | 7.2 | -7.3 | 3.5e-13 | -0.07 | 0.86 | 0.01 | FALSE |
5 | GTEx | Esophagus Mucosa | SSBP4 | 0.14 | 0.10 | lasso | 2 | 0.14 | 1.3e-09 | 7.4 | -6.7 | 2.3e-11 | -0.05 | 1.00 | 0.00 | FALSE |
6 | GTEx | Muscle Skeletal | MAU2 | 0.09 | 0.04 | lasso | 4 | 0.05 | 5.1e-06 | 6.0 | -5.6 | 1.8e-08 | 0.05 | 0.02 | 0.98 | FALSE |
7 | GTEx | Muscle Skeletal | SSBP4 | 0.09 | 0.07 | lasso | 3 | 0.07 | 1.3e-07 | 7.3 | -7.5 | 7.2e-14 | -0.10 | 1.00 | 0.00 | FALSE |
8 | GTEx | Skin Sun Exposed Lower leg | SSBP4 | 0.12 | 0.12 | lasso | 3 | 0.11 | 2.9e-09 | 7.4 | -7.4 | 1.8e-13 | -0.08 | 1.00 | 0.00 | FALSE |
9 | GTEx | Thyroid | ARRDC2 | 0.14 | 0.01 | enet | 5 | 0.01 | 2.7e-02 | 7.3 | -7.7 | 1.2e-14 | -0.45 | 0.19 | 0.07 | TRUE |
10 | GTEx | Thyroid | SSBP4 | 0.09 | 0.11 | lasso | 6 | 0.10 | 8.2e-08 | 7.3 | -7.1 | 1.3e-12 | -0.06 | 1.00 | 0.00 | FALSE |
11 | GTEx | Whole Blood | ELL | 0.10 | 0.03 | enet | 17 | 0.04 | 1.2e-04 | 7.3 | 6.8 | 8.4e-12 | 0.08 | 0.81 | 0.01 | FALSE |
12 | GTEx | Whole Blood | LRRC25 | 0.12 | 0.01 | enet | 7 | 0.02 | 1.0e-02 | 7.2 | -6.4 | 2.1e-10 | -0.02 | 0.59 | 0.02 | FALSE |
13 | METSIM | Adipose | ELL | 0.08 | 0.05 | lasso | 7 | 0.06 | 7.1e-09 | 7.5 | 8.0 | 1.2e-15 | 0.08 | 1.00 | 0.00 | TRUE |
14 | METSIM | Adipose | IL12RB1 | 0.05 | 0.05 | lasso | 3 | 0.04 | 2.8e-07 | -4.7 | 5.2 | 1.6e-07 | 0.16 | 1.00 | 0.00 | FALSE |
15 | METSIM | Adipose | LRRC25 | 0.04 | 0.01 | bslmm | 385 | 0.01 | 2.8e-02 | 6.7 | -6.5 | 8.2e-11 | -0.01 | 0.13 | 0.03 | FALSE |
16 | NTR | Blood | LRRC25 | 0.03 | 0.01 | lasso | 4 | 0.01 | 2.9e-04 | 6.7 | -5.3 | 1.4e-07 | -0.06 | 0.37 | 0.18 | FALSE |
17 | ROSMAP | Brain Pre-frontal Cortex | ELL | 0.27 | 0.39 | lasso | 7 | 0.39 | 4.0e-53 | 7.6 | -7.6 | 3.3e-14 | -0.07 | 1.00 | 0.00 | FALSE |
18 | ROSMAP | Brain Pre-frontal Cortex | LRRC25 | 0.09 | 0.02 | blup | 383 | 0.07 | 7.4e-09 | 1.1 | -6.0 | 2.4e-09 | 0.07 | 0.96 | 0.00 | FALSE |
19 | YFS | Blood | ELL | 0.23 | 0.41 | enet | 24 | 0.43 | 2.6e-158 | 7.2 | 6.0 | 2.2e-09 | 0.07 | 0.86 | 0.14 | FALSE |
20 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | ARRDC2 | 0.05 | 0.02 | blup | 46 | 0.02 | 5.0e-03 | 2.7 | -5.6 | 1.9e-08 | -0.03 | 0.06 | 0.04 | FALSE |
21 | The Cancer Genome Atlas | Breast Invasive Carcinoma | IL12RB1 | 0.06 | 0.03 | lasso | 5 | 0.05 | 3.9e-10 | -7.5 | 7.3 | 3.3e-13 | 0.27 | 1.00 | 0.00 | FALSE |
22 | The Cancer Genome Atlas | Breast Invasive Carcinoma | LRRC25 | 0.06 | 0.07 | enet | 13 | 0.06 | 5.9e-13 | 6.5 | -6.9 | 5.6e-12 | -0.04 | 0.92 | 0.08 | FALSE |
23 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | LRRC25 | 0.14 | 0.07 | enet | 5 | 0.10 | 8.3e-06 | 6.7 | -6.2 | 4.0e-10 | -0.01 | 0.13 | 0.23 | FALSE |
24 | The Cancer Genome Atlas | Colon Adenocarcinoma | LRRC25 | 0.06 | 0.05 | blup | 44 | 0.04 | 1.5e-03 | 7.3 | -6.0 | 1.8e-09 | -0.08 | 0.01 | 0.92 | FALSE |
25 | The Cancer Genome Atlas | Colon Adenocarcinoma | SSBP4 | 0.08 | 0.05 | enet | 9 | 0.07 | 6.7e-05 | 7.8 | -6.1 | 1.1e-09 | -0.01 | 0.01 | 0.97 | FALSE |
26 | The Cancer Genome Atlas | Glioblastoma Multiforme | ELL | 0.13 | 0.10 | blup | 46 | 0.08 | 1.9e-03 | 7.6 | -7.9 | 3.5e-15 | -0.06 | 0.02 | 0.87 | FALSE |
27 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | IL12RB1 | 0.05 | 0.03 | enet | 11 | 0.05 | 2.3e-06 | 6.2 | 6.4 | 1.6e-10 | 0.22 | 0.68 | 0.16 | FALSE |
28 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | SSBP4 | 0.04 | 0.03 | blup | 37 | 0.04 | 1.6e-05 | 7.6 | -7.9 | 3.1e-15 | -0.07 | 0.01 | 0.99 | FALSE |
29 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | IL12RB1 | 0.10 | 0.08 | blup | 58 | 0.09 | 6.9e-10 | -4.5 | 8.0 | 1.2e-15 | 0.28 | 1.00 | 0.00 | FALSE |
30 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | MAST3 | 0.04 | 0.02 | blup | 65 | 0.01 | 7.3e-02 | -2.8 | 5.2 | 1.8e-07 | 0.16 | 0.01 | 0.14 | FALSE |
31 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SSBP4 | 0.02 | 0.02 | blup | 37 | 0.03 | 3.7e-04 | 7.2 | -5.6 | 2.2e-08 | -0.03 | 0.02 | 0.88 | FALSE |
32 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | TM6SF2 | 0.04 | 0.03 | blup | 35 | 0.03 | 2.5e-04 | 5.8 | 5.9 | 3.4e-09 | -0.04 | 0.01 | 0.98 | FALSE |
33 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C19orf50 | 0.12 | 0.00 | enet | 11 | 0.01 | 6.5e-02 | 1.1 | -5.5 | 4.8e-08 | 0.00 | 0.01 | 0.59 | FALSE |
34 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | SSBP4 | 0.06 | 0.07 | enet | 6 | 0.07 | 5.6e-05 | 7.2 | -6.7 | 1.9e-11 | -0.04 | 0.02 | 0.98 | FALSE |
35 | The Cancer Genome Atlas | Brain Lower Grade Glioma | IL12RB1 | 0.05 | 0.03 | lasso | 3 | 0.03 | 1.3e-04 | -4.7 | 6.2 | 4.2e-10 | 0.18 | 0.32 | 0.22 | FALSE |
36 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LRRC25 | 0.07 | 0.08 | blup | 46 | 0.09 | 2.2e-10 | 6.5 | -6.7 | 2.3e-11 | -0.03 | 0.26 | 0.74 | FALSE |
37 | The Cancer Genome Atlas | Brain Lower Grade Glioma | SSBP4 | 0.03 | 0.03 | lasso | 1 | 0.03 | 9.7e-05 | 6.5 | -6.5 | 8.9e-11 | -0.05 | 0.15 | 0.63 | FALSE |
38 | The Cancer Genome Atlas | Lung Adenocarcinoma | ARRDC2 | 0.04 | 0.01 | enet | 7 | 0.03 | 5.3e-04 | -7.5 | -9.7 | 3.2e-22 | -0.18 | 0.02 | 0.05 | TRUE |
39 | The Cancer Genome Atlas | Lung Adenocarcinoma | IL12RB1 | 0.10 | 0.08 | enet | 13 | 0.07 | 3.9e-08 | -4.5 | 6.6 | 3.2e-11 | 0.19 | 1.00 | 0.00 | FALSE |
40 | The Cancer Genome Atlas | Lung Adenocarcinoma | LRRC25 | 0.04 | 0.01 | blup | 45 | 0.02 | 6.2e-04 | 6.5 | -7.7 | 1.6e-14 | -0.06 | 0.02 | 0.95 | TRUE |
41 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C19orf62 | 0.03 | 0.01 | blup | 60 | 0.01 | 1.9e-02 | 4.1 | -5.1 | 2.9e-07 | -0.10 | 0.00 | 0.16 | FALSE |
42 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | IL12RB1 | 0.07 | 0.04 | blup | 58 | 0.06 | 4.9e-07 | -2.9 | 7.3 | 2.5e-13 | 0.31 | 0.89 | 0.09 | FALSE |
43 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | LRRC25 | 0.06 | 0.02 | blup | 46 | 0.04 | 5.6e-05 | 6.7 | -5.5 | 2.9e-08 | -0.07 | 0.02 | 0.95 | FALSE |
44 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | LRRC25 | 0.07 | 0.03 | blup | 46 | 0.02 | 8.5e-03 | 6.7 | -7.9 | 3.6e-15 | -0.08 | 0.02 | 0.75 | FALSE |
45 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SSBP4 | 0.06 | 0.02 | blup | 37 | 0.05 | 4.3e-04 | 7.6 | -5.7 | 1.4e-08 | -0.10 | 0.01 | 0.92 | TRUE |
46 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | LRRC25 | 0.12 | 0.03 | blup | 45 | 0.01 | 1.1e-01 | 6.5 | -7.7 | 2.0e-14 | -0.08 | 0.01 | 0.22 | FALSE |
47 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ELL | 0.03 | 0.03 | blup | 47 | 0.01 | 1.2e-02 | 7.6 | -7.2 | 4.8e-13 | -0.04 | 0.01 | 0.94 | FALSE |
48 | The Cancer Genome Atlas | Prostate Adenocarcinoma | IL12RB1 | 0.09 | 0.01 | blup | 58 | 0.05 | 1.2e-05 | -4.7 | 6.3 | 2.9e-10 | 0.28 | 0.88 | 0.01 | FALSE |
49 | The Cancer Genome Atlas | Prostate Adenocarcinoma | SSBP4 | 0.04 | 0.08 | enet | 13 | 0.08 | 8.4e-09 | 7.8 | -7.3 | 3.9e-13 | -0.06 | 0.01 | 0.99 | FALSE |
50 | The Cancer Genome Atlas | Stomach Adenocarcinoma | OCEL1 | 0.18 | 0.08 | blup | 53 | 0.11 | 1.4e-08 | 4.1 | 5.4 | 5.3e-08 | 0.04 | 0.00 | 0.81 | TRUE |
51 | The Cancer Genome Atlas | Stomach Adenocarcinoma | SSBP4 | 0.05 | 0.00 | blup | 37 | 0.02 | 8.7e-03 | 4.0 | -6.1 | 9.9e-10 | -0.05 | 0.02 | 0.18 | FALSE |
52 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | IL12RB1 | 0.10 | 0.01 | enet | 10 | 0.06 | 2.6e-03 | -7.5 | 5.4 | 6.2e-08 | 0.23 | 0.03 | 0.12 | FALSE |
53 | The Cancer Genome Atlas | Thyroid Carcinoma | ELL | 0.06 | 0.06 | blup | 46 | 0.09 | 1.2e-08 | 7.5 | -7.1 | 1.7e-12 | -0.03 | 0.02 | 0.98 | FALSE |
54 | The Cancer Genome Atlas | Thyroid Carcinoma | ISYNA1 | 0.04 | 0.00 | blup | 34 | 0.02 | 4.8e-03 | 4.0 | 6.6 | 3.5e-11 | 0.07 | 0.02 | 0.85 | FALSE |
55 | The Cancer Genome Atlas | Thyroid Carcinoma | LRRC25 | 0.05 | 0.08 | lasso | 3 | 0.07 | 5.4e-07 | 6.7 | -7.0 | 3.4e-12 | -0.04 | 0.06 | 0.94 | FALSE |
56 | The Cancer Genome Atlas | Thyroid Carcinoma | TM6SF2 | 0.05 | 0.04 | blup | 34 | 0.05 | 2.8e-05 | 5.8 | 5.8 | 7.0e-09 | -0.03 | 0.01 | 0.99 | FALSE |